# US 2022/0023496 A1 · Nanofiber structures and methods of manufacture and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0023496 A1
- Document ID: US20220023496A1
- Status: Published application
- Kind: A1
- Application number: 17/413,147
- Filed: 2019-12-16
- Published: 2022-01-27
- Earliest claimed: 2018-12-14
- Assignees: Board of Regents of the University of Nebraska
- Applicants: Board of Regents of the University of Nebraska
- Inventors: Jingwei XIE; Shixuan CHEN
- Web page: https://patentgrep.com/patent/US20220023496A1

## CPC

- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61P 19/00: Drugs for skeletal disorders
- C12N 5/0656: {Adult fibroblasts}
- D01D 5/0007: {Electro-spinning (non-woven fabrics produced by electro-spinning D04H1/728)}
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- A61L 2300/406: Antibiotics
- A61L 2300/414: Growth factors
- A61L 2300/418: Agents promoting blood coagulation, blood-clotting agents, embolising agents
- A61L 2300/426: Immunomodulating agents, i.e. cytokines, interleukins, interferons
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- B82Y 40/00: Manufacture or treatment of nanostructures
- C12N 2513/00: 3D culture
- C12N 2533/30: Synthetic polymers
- C12N 2535/00: Supports or coatings for cell culture characterised by topography
- D10B 2331/041: derived from hydroxy-carboxylic acids, e.g. lactones
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- D01D: MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- D10B: INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES

## Abstract

Nanofiber structures are provided as well as methods of use thereof and methods of making.

## Claims

### Claim at position 1

1: A method for producing a nanofiber or microfiber structure, said method comprising:
a) fixing at least one point of a nanofiber or microfiber mat, and
b) expanding the nanofiber or microfiber mat after step a) by exposing the nanofiber or microfiber mat to gas bubbles,
thereby producing said nanofiber or microfiber structure.

### Claim at position 2 (depends on 1)

2: The method of claim 1, wherein step b) comprises exposing the nanofiber or microfiber mat to a subcritical fluid and depressurizing.

### Claim at position 3 (depends on 2)

3: The method of claim 2, wherein said subcritical fluid comprises CO2, N2, N2O, hydrocarbons, or fluorocarbons.

### Claim at position 4 (depends on 2)

4: The method of claim 2, wherein said subcritical fluid is subcritical CO2.

### Claim at position 5 (depends on 2)

5: The method of claim 2, wherein said exposure comprises immersing said nanofiber or microfiber mat in said subcritical fluid.

### Claim at position 6 (depends on 1)

6: The method of claim 1, wherein said nanofiber or microfiber mat comprises electrospun fibers.

### Claim at position 7 (depends on 1)

7: The method of claim 1, wherein said nanofiber or microfiber mat comprises a plurality of uniaxially-aligned nanofibers or microfibers, random nanofibers or microfibers, and/or entangled nanofibers or microfibers.

### Claim at position 8 (depends on 1)

8: The method of claim 1, further comprising synthesizing said nanofiber or microfiber mat by electrospinning prior to step a).

### Claim at position 9 (depends on 1)

9: The method of claim 1, further comprising cutting said nanofiber or microfiber mat prior to step a).

### Claim at position 10 (depends on 1)

10: The method of claim 1, wherein said nanofiber or microfiber mat comprises polycaprolactone (PCL).

### Claim at position 11 (depends on 1)

11: The method of claim 1, wherein said nanofiber or microfiber mat comprises a poloxamer.

### Claim at position 12 (depends on 11)

12: The method of claim 11, wherein said poloxamer is poloxamer 407.

### Claim at position 13 (depends on 1)

13: The method of claim 1, wherein step a) comprises thermally fixing at least one point of said nanofiber or microfiber mat.

### Claim at position 14 (depends on 1)

14: The method of claim 1, wherein step a) comprises chemically fixing at least one point of said nanofiber or microfiber mat.

### Claim at position 15 (depends on 1)

15: The method of claim 1, wherein step a) comprises fixing at least two individual points of said nanofiber or microfiber mat.

### Claim at position 16 (depends on 1)

16: The method of claim 1, wherein step a) comprises fixing at least an entire side of said nanofiber or microfiber mat.

### Claim at position 17 (depends on 1)

17: The method of claim 1, wherein said nanofiber or microfiber structure is a cylinder, sphere, tube, or hollow sphere.

### Claim at position 18 (depends on 1)

18: The method of claim 1, wherein said nanofiber or microfiber structure comprises an active agent.

### Claim at position 19 (depends on 18)

19: The method of claim 18, wherein said active agent is selected from the group consisting of a therapeutic agent, a growth factor, a signaling molecule, a cytokine, a hemostatic agent, an antimicrobial, and an antibiotic.

### Claim at position 20 (depends on 1)

20: The method of claim 1, wherein said nanofiber or microfiber structure comprises holes or wells.

### Claim at position 21 (depends on 1)

21: The method of claim 1, further comprising crosslinking the nanofiber or microfiber structure.

### Claim at position 22 (depends on 1)

22: The method of claim 1, wherein said nanofiber or microfiber structure further comprise a material selected from the group consisting of gelatin, chitosan, starch, pectin, cellulose, methylcellulose, sodium polyacrylate, and starch-acrylonitrile co-polymers.

### Claim at position 23 (depends on 1)

23: The method of claim 1, further comprising blocking at least one side of the nanofiber or microfiber structure with a nanofiber mat or membrane.

### Claim at position 24

24: A method for producing a nanofiber or microfiber structure, said method comprising:
a) thermally fixing at least one point of a nanofiber or microfiber mat, wherein said nanofiber or microfiber mat comprises polycaprolactone (PCL) and a poloxamer, wherein said nanofiber or microfiber mat comprises electrospun fibers, and
b) expanding the nanofiber or microfiber mat after step a) by exposing the nanofiber or microfiber mat to subcritical fluid CO2 and depressurizing,
thereby producing said nanofiber or microfiber structure.

### Claim at position 25 (depends on 1)

25: A nanofiber or microfiber structure produced by the method of claim 1.

### Claim at position 26 (depends on 25)

26: A method of promoting bone regeneration in a subject, said method comprising administering a nanofiber or microfiber structure of claim 25 to a bone defect in said subject.
